Patents by Inventor Steven A. Keyser

Steven A. Keyser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110031190
    Abstract: An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
    Type: Application
    Filed: June 10, 2010
    Publication date: February 10, 2011
    Applicant: ACQUISCI, INC.
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Publication number: 20110031172
    Abstract: An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
    Type: Application
    Filed: June 10, 2010
    Publication date: February 10, 2011
    Applicant: ACQUISCI, INC.
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Publication number: 20100318014
    Abstract: Methods are provided for treatment of acute ischemic brain stroke based on the delivery of a measured amount of ozone to a sample of a mammalian patient's blood, blood fractionate or other biological fluid through the use of an ozone delivery system. The ozone-treated fluid, having absorbed a quantifiable absorbed-dose of ozone, is subsequently reinfused into the same patient and the autologous blood sample provides therapeutic effects to the patient, such as reduction in edema associated with the ischemic penumbra, improvement in impaired blood flow to the area surrounding the infarct, relaxation of the vascular endothelium and reduction of inflammation.
    Type: Application
    Filed: June 21, 2010
    Publication date: December 16, 2010
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Publication number: 20100316727
    Abstract: Methods for therapeutic treatment of inflammatory conditions in a mammalian patient provide clinical benefits including reduction of inflammation, vasorelaxation, reduction in edema and increased blood flow, the methods generally comprising extracorporeal treatment of blood, blood fractionate, or other biological fluid to expose such fluids to a precise, measured amount of ozone to produce a blood or biological fluid having a quantified absorbed dose of ozone, and reinfusing the treated biological fluid to the patient to provide therapeutic effects beneficial in the treatment of inflammatory disorders and related symptoms or conditions.
    Type: Application
    Filed: June 21, 2010
    Publication date: December 16, 2010
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Publication number: 20100316730
    Abstract: Methods of treating cardiovascular diseases, including atherosclerosis, peripheral arterial occlusive disease, congestive heart failure, hypertension, cerebrovascular disease, dyslipidemia and vasospastic disorders such as Raynaud's disease, in a mammalian patient involve extracorporeally subjecting an amount of blood, blood fractionate or other biological fluid from a patient to a measured amount of ozone delivered by an ozone delivery system, resulting in the absorption of a quantifiable absorbed-dose of ozone and reinfusing the treated fluid into the patient to therapeutically treat cardiovascular disease and related conditions.
    Type: Application
    Filed: June 21, 2010
    Publication date: December 16, 2010
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Patent number: 7736494
    Abstract: An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
    Type: Grant
    Filed: October 11, 2004
    Date of Patent: June 15, 2010
    Assignee: AcquiSci, Inc.
    Inventors: Joseph S. Latino, Steven A. Keyser
  • Publication number: 20050189302
    Abstract: A method to inactivate viruses in a biological fluid and a non-fluid target to produce a non-infectious biological fluid or non-fluid target. The method involves subjecting an amount of a fluid or a target containing a virus including lipid-enveloped viruses, to an amount of ozone delivered by an ozone delivery system. The method may provide for maintaining the biological integrity of the biological fluid or the non-fluid target. All gas contacting surfaces of the system, including one or more gas-fluid contact devices are made from ozone-inert construction.
    Type: Application
    Filed: October 11, 2004
    Publication date: September 1, 2005
    Inventors: Joseph Latino, Steven Keyser
  • Publication number: 20050087498
    Abstract: An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
    Type: Application
    Filed: August 2, 2004
    Publication date: April 28, 2005
    Inventors: Steven Keyser, Joseph Latino
  • Publication number: 20050051497
    Abstract: A method to inactivate viruses in a biological fluid and a non-fluid target to produce a non-infectious biological fluid or non-fluid target. The method involves subjecting an amount of a fluid or a target containing a virus including lipid-enveloped viruses, to an amount of ozone delivered by an ozone delivery system. The method may provide for maintaining the biological integrity of the biological fluid or the non-fluid target. All gas contacting surfaces of the system, including one or more gas-fluid contact devices are made from ozone-inert construction.
    Type: Application
    Filed: August 2, 2004
    Publication date: March 10, 2005
    Inventors: Joseph Latino, Steven Keyser
  • Publication number: 20050051498
    Abstract: An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
    Type: Application
    Filed: October 11, 2004
    Publication date: March 10, 2005
    Inventors: Joseph Latino, Steven Keyser